Comparison between single-agent and combination chemiotherapy against uterine mesenchymal tumors. Doxorubicine for LMS and ifosfamide and cisplatin for MMT are the most effective antineoplastic drugs in single-agent chemiotherapy. Combination chemiotherapy increases response rate as well as toxicity, but the impact on survival is unclear.
Chemotherapy in Uterine Mesenchymal Tumors
BERGAMINI, VALENTINO;FRANCHI, Massimo Piergiuseppe
2004-01-01
Abstract
Comparison between single-agent and combination chemiotherapy against uterine mesenchymal tumors. Doxorubicine for LMS and ifosfamide and cisplatin for MMT are the most effective antineoplastic drugs in single-agent chemiotherapy. Combination chemiotherapy increases response rate as well as toxicity, but the impact on survival is unclear.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
